Latest filing published 09 Feb 2021 for Neurocrine Biosciences INC, €67k.
Filing timeline
BuySaleInsider track record
Haig P. Bozigian: trading record in brief
Haig P. Bozigian discloses dealings in Neurocrine Biosciences Inc to SEC (Form 4). In total, 134 filings cover trades dated from 5 February 2008 to 8 February 2021.
Sales make up the whole of the open-market record (91 sales, €46.9M). Other entries cover 1 share grant and 42 option exercises. So far in 2021, the count stands at no purchases and 4 sales.
The latest filing, published on 9 February 2021, reports an open-market sale of €67k in Neurocrine Biosciences Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. Section 16 rules allow two business days to file each Form 4. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Haig P. Bozigian
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 704 shares@ US$113.790.1% of flowCommon StockSEC:0001209191-21-009130:0
- 824 shares@ US$116.850.1% of flowCommon StockSEC:0001209191-21-009130:1
- 1,395 shares@ US$116.780.3% of flowCommon StockSEC:0001209191-21-009130:2
- 1,623 shares@ US$116.790.3% of flowCommon StockSEC:0001209191-21-009130:3
- 2,257 shares@ US$90.74281.5% of flowCommon StockSEC:0001209191-20-058539:0
- 2,257 shares@ US$118.892.0% of flowCommon StockSEC:0001209191-20-045742:0
- 9,094 shares@ US$35.992.7% of flowCommon StockSEC:0001209191-20-029401:0
- 9,094 shares@ US$114.948.5% of flowCommon StockSEC:0001209191-20-029401:1
- 18,571 shares@ US$43.246.5% of flowCommon StockSEC:0001209191-20-029401:2
- 18,571 shares@ US$114.9417.4% of flowCommon StockSEC:0001209191-20-029401:3
- 15,833 shares@ US$81.4910.5% of flowCommon StockSEC:0001209191-20-029401:4
- 15,833 shares@ US$114.9414.8% of flowCommon StockSEC:0001209191-20-029401:5
- 18,057 shares@ US$81.0511.9% of flowCommon StockSEC:0001209191-20-029401:6
- 18,057 shares@ US$114.9416.9% of flowCommon StockSEC:0001209191-20-029401:7
- 1,934 shares@ US$99.460.9% of flowCommon StockSEC:0001209191-20-026064:0
- 1,623 shares@ US$103.330.7% of flowCommon StockSEC:0001209191-20-008484:0
- 1,342 shares@ US$103.000.4% of flowCommon StockSEC:0001209191-20-007674:0
- 704 shares@ US$103.060.2% of flowCommon StockSEC:0001209191-20-007674:1
- 1,395 shares@ US$101.560.4% of flowCommon StockSEC:0001209191-20-007674:2
- 18,756 shares@ US$32.991.3% of flowCommon StockSEC:0001209191-19-043914:0
- 18,756 shares@ US$91.743.6% of flowCommon StockSEC:0001209191-19-043914:1
- 25,600 shares@ US$43.242.3% of flowCommon StockSEC:0001209191-19-043914:2
- 25,600 shares@ US$93.525.0% of flowCommon StockSEC:0001209191-19-043914:3
- 30,680 shares@ US$32.992.1% of flowCommon StockSEC:0001209191-19-042522:0
- 30,680 shares@ US$87.505.5% of flowCommon StockSEC:0001209191-19-042522:1
25 of 126 declarations
